EGFR and non-small cell lung carcinoma: The oligoprogression concept is characterized by a limited number and/or sites of metastases in which a disease progression appears, and a more indolent tumor biology, raised specifically for oncogene addicted non-small cell lung cancer (NSCLC), including the epidermal growth factor receptor (EGFR)-mutant group.